glp 1 drugs fda approved The has the first pill version of GLP-1 drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight FDA approves first weight-loss GLP-1
Description
Hepatology (2006) 43:17381

semaglutide was second (HbA1-c: MD: -1.5%

And the numbers were clear

In the DUAL I trial, participants taking Xultophy required a lower average of 39 units of insulin per day, compared to 62 units for those on Tresiba alone

Bydureon: Summary of product characteristics
